BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/5/2025 6:43:30 AM | Browse: 10 | Download: 22
 |
Received |
|
2025-08-26 07:06 |
 |
Peer-Review Started |
|
2025-08-26 07:06 |
 |
First Decision by Editorial Office Director |
|
2025-09-20 02:06 |
 |
Return for Revision |
|
2025-09-20 02:06 |
 |
Revised |
|
2025-09-25 14:13 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-11-17 02:44 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-11-17 09:33 |
 |
Articles in Press |
|
2025-11-17 09:33 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-12-01 00:30 |
 |
Publish the Manuscript Online |
|
2025-12-05 06:43 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Perspectives on monitoring and diagnosis of chemotherapy-induced cardiotoxicity
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Arnold Méndez-Toro |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arnold Méndez-Toro, Professor, Department of Cardiology, Hospital Universitario Nacional de Colombia, Cl. 44 #59-75, Bogota 111321, Bogotá, Colombia. arnold.mendez@hun.edu.co |
| Key Words |
Cardiotoxicity; Chemotherapy; Echocardiography; Global longitudinal strain; Myocarditis; Risk assessment |
| Core Tip |
The accurate identification and monitoring of chemotherapy-related cardiotoxicity demand inclusive patient selection and robust diagnostic strategies. Our study demonstrates that real-world cohorts often reflect local epidemiological patterns rather than exclusionary criteria, underscoring the need for comprehensive inclusion of both solid and hematologic malignancies. Retrospective designs, while valuable, may overlook subclinical conditions such as myocarditis and lack precise chemotherapy dose tracking. Integrating advanced imaging, standardized biomarker surveillance, and multicenter collaboration in prospective registries can close these gaps, enhance diagnostic certainty, and improve risk stratification. Such approaches will strengthen cardio-oncology practice and optimize long-term cardiovascular outcomes in cancer patients. |
| Publish Date |
2025-12-05 06:43 |
| Citation |
Méndez-Toro A. Perspectives on monitoring and diagnosis of chemotherapy-induced cardiotoxicity. World J Clin Cases 2025; 13(34): 113256 |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i34/113256.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i34.113256 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345